An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy Interventions: Drug: Casimersen; Drug: Golodirsen Sponsor: Sarepta Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials